New Science Ventures
PE / VC · London · United Kingdom
Stages
Investment region
Industries
Profile
New Science Ventures, LLC (NSV) is a venture capital firm based in Connecticut and London. They invest in companies employing novel scientific approaches within the life sciences and information technology sectors. Known for creating value through breakthrough science, NSV distinguishes itself by focusing on significant unmet needs, leveraging both early and late-stage investments to support innovative technologies in its targeted fields. NSV targets the life sciences and information technology sectors, with investments covering a wide range of sub-sectors. They provide funding for early-stage through late-stage companies, although specific check sizes are not mentioned. Their geographical focus spans multiple regions due to their multiple bases of operation. The firm has invested in companies such as Trellis Bioscience, known for developing monoclonal antibodies to treat infectious diseases, and Antevia Networks, a telecom equipment vendor focused on private 5G networks. Glydways, a global leader in Automated Transit Networks, is another notable investment illustrating their diversified venture strategy in technology-oriented sectors.
联系人 (2)
| 姓名 | Title | 电话 | ||
|---|---|---|---|---|
| Partner | — | — | — | |
| Partner and Chief Financial Officer | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.